Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study
Money D, Lee T, O’Brien C, Brophy J, Bitnun A, Kakkar F, Boucoiran I, Alimenti A, Vaudry W, Singer J, Sauvé LJ; Canadian Perinatal HIV Surveillance Program
Tell us what you think